456PFirst-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumours

Authors

Keywords

Journal

Volume 30, Issue Supplement_5, Pages -

Publisher

Oxford University Press (OUP)

Online

2019-10-01

DOI

10.1093/annonc/mdz244.018

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started